Eddit
Aus coViki
(Unterschied zwischen Versionen)
(90 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) | |||
Zeile 1: | Zeile 1: | ||
__NOTOC__ | __NOTOC__ | ||
*'''[[Further reading]]''' | *'''[[Further reading]]''' | ||
− | |||
*'''[[Unproven ideas]]''' | *'''[[Unproven ideas]]''' | ||
+ | |||
*'''[[Reviews on covid19 disease]]''' | *'''[[Reviews on covid19 disease]]''' | ||
+ | *'''[[Clinical guidelines and advice]]''' | ||
+ | *'''[[Respiration mgmt]]''' | ||
+ | *'''[[Diagnosis (Laboratory)]]''' | ||
+ | *'''[[Diagnosis (Lung CT, Sonography)]]''' | ||
+ | *'''[[Diagnosis (other modalities)]]''' | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
*'''[[Structure of covid19]]''' | *'''[[Structure of covid19]]''' | ||
+ | |||
*'''[[Target binding and uptake]]''' | *'''[[Target binding and uptake]]''' | ||
*'''[[Cytopathic effects]]''' | *'''[[Cytopathic effects]]''' | ||
− | |||
*'''[[Secretion and shedding]]''' | *'''[[Secretion and shedding]]''' | ||
− | |||
− | |||
Zeile 44: | Zeile 37: | ||
*'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | ||
− | + | ||
+ | |||
+ | *'''[[Pathobiology]]''' | ||
+ | |||
+ | |||
+ | *'''[[Disease Models]]''' | ||
+ | |||
+ | |||
+ | *'''[[Similar diseases and pathomechanisms]]''' | ||
Zeile 55: | Zeile 56: | ||
*'''[[Co-Infection]]''' | *'''[[Co-Infection]]''' | ||
− | |||
− | |||
*'''[[Pulmonary embolism, coagulation]]''' | *'''[[Pulmonary embolism, coagulation]]''' | ||
− | |||
− | |||
− | |||
− | *'''[[ | + | *'''[[Hematology]]''' |
− | |||
− | *'''[[ | + | *'''[[Heart]]''' |
− | |||
− | |||
− | *'''[[ | + | *'''[[Neurology, ophthalmology, orl]]''' |
− | |||
− | *'''[[ | + | *'''[[Dermatology]]''' |
− | *'''[[ | + | *'''[[Gastroenterology, hepatology]]''' |
− | *'''[[ | + | *'''[[Kidney, urology]]''' |
− | + | *'''[[The morbid survivor]]''' | |
+ | *'''[[Risk and special populations]]''' | ||
− | |||
− | |||
− | |||
+ | *'''[[Case reports]]''' | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
*'''[[Case series]]''' | *'''[[Case series]]''' | ||
− | |||
− | |||
− | |||
− | |||
*'''[[Registries]]''' | *'''[[Registries]]''' | ||
− | |||
+ | *'''[[Trials]]''' | ||
− | |||
*'''[[Candidate Compounds Covid19]]''' | *'''[[Candidate Compounds Covid19]]''' | ||
− | + | *'''[[Other routes of infection]]''' | |
− | *'''[[ | + | |
+ | *'''[[Biophysics of aerosols]]''' | ||
− | |||
− | |||
− | |||
*'''[[Passive protective equipment]]''' | *'''[[Passive protective equipment]]''' | ||
− | + | ||
− | + | ||
Zeile 147: | Zeile 124: | ||
*'''[[Mental aspects of health professionals]]''' | *'''[[Mental aspects of health professionals]]''' | ||
− | |||
*'''[[Socio-psychiatric aspects of the status hygienicus]]''' | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' | ||
− | + | ||
− | + | ||
*'''[[Avoiding clinical medicine in other diseases]]''' | *'''[[Avoiding clinical medicine in other diseases]]''' | ||
− | + | ||
Zeile 162: | Zeile 138: | ||
*'''[[Economic aspects of the status hygienicus]]''' | *'''[[Economic aspects of the status hygienicus]]''' | ||
− | |||
− | |||
Zeile 176: | Zeile 150: | ||
*'''[[Epidemiology]]''' | *'''[[Epidemiology]]''' | ||
− | |||
− | + | ||
+ | |||
+ | *'''[[Remission, recurrence and persistence]]''' | ||
+ | |||
+ | |||
+ | |||
+ | *'''[[Failure of executive measures]]''' | ||
---- | ---- | ||
*'''[[Failure of politics and public health guidance]]''' | *'''[[Failure of politics and public health guidance]]''' | ||
− | + | ||
*'''[[Political abuse of Covid19]]''' | *'''[[Political abuse of Covid19]]''' | ||
− | |||
*'''[[Lost people]]''' | *'''[[Lost people]]''' | ||
− | + | ||
− | + | ||
*'''[[Lost civilization]]''' | *'''[[Lost civilization]]''' | ||
+ | |||
---- | ---- | ||
Zeile 204: | Zeile 182: | ||
− | *'''[[PrePrint scene''' | + | |
− | + | {{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} | |
+ | {{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}} | ||
+ | |||
+ | |||
+ | *'''[[PrePrint scene]]''' | ||
+ | |||
*'''[[from the ads]]''' | *'''[[from the ads]]''' | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
*'''[[Current state of coviki.org]]''' | *'''[[Current state of coviki.org]]''' | ||
+ | *'''[[on-topic personal thoughts]]''' |
Aktuelle Version vom 7. Juni 2020, 22:19 Uhr
27490990 2017. AVCpred: an integrated web server for prediction and design of antiviral compounds
25040500 2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system